These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16492522)

  • 1. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
    Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
    Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM; Sharon Z; Pauli BU; Lewis EJ
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of elastase on aminonucleoside nephrosis--on renal vascular system].
    Ono H; Hirabayashi K; Ono Y; Sagiya A; Kanaya H; Iidaka K
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):783-8. PubMed ID: 1479717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
    Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis.
    Grond J; Koudstaal J; Elema JD
    Kidney Int; 1985 Feb; 27(2):405-10. PubMed ID: 3990093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
    Whiteside C; Prutis K; Cameron R; Thompson J
    Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
    Hjalmarsson C; Lidell ME; Haraldsson B
    Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
    Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA
    Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the expression of basement membrane and type I collagen gene in focal glomerular sclerosis (FGS)].
    Nakamura T
    Nihon Jinzo Gakkai Shi; 1990 Nov; 32(11):1253-61. PubMed ID: 2082058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of increased glomerular permeability on the localization of immune aggregates and protamine-heparin aggregates in the rat.
    Weening JJ; Grond J; Hoedemaeker PJ
    Lab Invest; 1983 Nov; 49(5):619-25. PubMed ID: 6632777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ; Wilke WL; Fettman MJ
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on prevention and treatment of focal segmental glomerulosclerosis with heparin].
    Zhang BL; Li ZJ; Song LY; Zhou H; Wang WH; Zhang X
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jan; 16(1):26-8. PubMed ID: 14706199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A role for reactive oxygen species in the pathogenesis of focal glomerulosclerosis].
    Kawamoto S; Kawamura T
    Nihon Jinzo Gakkai Shi; 1996 Nov; 38(11):484-92. PubMed ID: 8958702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular metalloprotease activity modulates the development of focal segmental glomerulosclerosis.
    Sagar S; Gibbons N; Valderrama E; Singhal PC
    Clin Nephrol; 1995 Dec; 44(6):356-61. PubMed ID: 8719546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules.
    Keane WF; Raij L
    Lab Invest; 1985 Jun; 52(6):599-604. PubMed ID: 4010224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.